Major events with Dendreon have usually resulted in a significant effect on Prima.
Same old. However we all know the fundamentals for Prima are essentially unchanged.
What has changed is that it is now starkly clear that Prima, as a biotech in research phase, is a high risk speccy.
Many here, and I suspect elsewhere, had forgotten that. I've been criticised in the past on this forum for pointing that out and warning people to "don't bet the farm" on it.
I still have a lot of confidence in the future of Prima and Cvac. That's why I increased my holding by 50% yesterday.
As sure as night follows day, along the way to Phase III results, there will be a continuing roller coaster ride. It goes with the territory.
estimates required, page-3
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.015(5.36%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.0¢ | $833.4K | 2.824M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 388130 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 39940 | 3 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |